V CompBrief BY VELARION

Chief Commercial Officer · LENZ Therapeutics, Inc. (LENZ)

Shawn Olsson

FY2025 is the first fiscal year CompBrief holds for Shawn Olsson as a named executive officer of LENZ Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$2,387,388

3rd of 3 named executive officers at Lenz Therapeutics by FY2025 total.

3 named officers on file for LENZ Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. LENZ Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how LENZ Therapeutics’s whole pay program stands against its peers

  • LENZ Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LENZ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Free

Get Shawn Olsson’s full pay file as a PDF — free

More than this page: up to 10 years of Shawn’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Shawn Olsson and every company like it: Velarion Intel, free for 3 days, no card →

Shawn Olsson compensation by year

LENZ Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as LENZ Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$467,500
Bonus$0
Stock awards$0
Option awards$1,662,788
Non-equity incentive$243,100
Pension and deferred compensation$0
All other$14,000
Total$2,387,388

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LENZ Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001815776-26-000026, and prior-year filings.

How this page was built: the LENZ Therapeutics, Inc. filed document, accession 0001815776-26-000026. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option15,911—$6.04
Option59,063—$15.05
Option80,100—$26.34

Per the Outstanding Equity Awards at Fiscal Year-End table in LENZ Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

LENZ Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Evert SchimmelpenninkPresident and Chief Executive Officer$7,036,009
Marc OdrichChief Medical Officer$2,436,788
Shawn Olsson · this pageChief Commercial Officer$2,387,388

Shawn Olsson's compensation dossier, LENZ Therapeutics

You have read Shawn Olsson's totals and holdings. The dossier adds each equity grant LENZ Therapeutics disclosed for Shawn Olsson and LENZ Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full LENZ Therapeutics compensation record

free company brief
LENZ Therapeutics, Inc. (LENZ) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within LENZ Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order LENZ Therapeutics's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LENZ Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Shawn Olsson's compensation dossier